SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-18-042997
Filing Date
2018-02-14
Accepted
2018-02-13 17:51:33
Documents
3
Group Members
LENE SKOLEMETTE KIRSTINE AGGER

Document Format Files

Seq Description Document Type Size
1 SC 13G d535392dsc13g.htm SC 13G 64466
2 EX-99.1 d535392dex991.htm EX-99.1 8812
3 EX-99.2 d535392dex992.htm EX-99.2 11805
  Complete submission text file 0001193125-18-042997.txt   86614
Mailing Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100
Business Address SCHERFIGSVEJ 7 COPENHAGEN G7 DK-2100 4540307375
Lundbeckfond Invest A/S (Filed by) CIK: 0001591046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830 617-517-0730
scPharmaceuticals Inc. (Subject) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90193 | Film No.: 18605452
SIC: 2834 Pharmaceutical Preparations